Patent · US Active

Compositions and methods of treating retinal disease

US7973025B2 · kind B2 · utility

34Cited by

2References

3Claims

0Family size

Assignee

NEURON SYSTEMS, INC. · US

Inventors

Thomas A. Jordan · Asheboro, US
John E. Dowling · Boston, US
John C. Chabala · Mountainside, US

Key dates

Filing date	May 26, 2006
Grant date	Jul 5, 2011
Priority date	—
Expiry date	Jul 23, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D333/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.